CT Imaging for Guiding PA-TACE for HCC

CompletedOBSERVATIONAL

Enrollment

1,770

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions

Carcinoma, Hepatocellular

Interventions

PROCEDURE

postoperative adjuvant transarterial chemoembolization

HCC patients received hepatectomy and PA-TACE.

Trial Locations (1)

ZhuJiang Hospital of Southern Medical University, Guangzhou

All Listed Sponsors

lead

Zhujiang Hospital

OTHER

NCT06156748 - CT Imaging for Guiding PA-TACE for HCC | Biotech Hunter | Biotech Hunter